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Dr William Jordan (Birmingham, Ala). First, I want to
congratulate Dr Timaran and his colleagues with his presentation
of this important treatment algorithm for carotid artery stenting.
In their series, he has demonstrated the utility of using additional
imaging of contrast-enhanced MRA to direct the planning of the
procedures specifically related to the aortic arch morphology, the
location of the stenosis, and the course of the distal carotid artery.
The proximal and distal arterial anatomy is not well imaged with
duplex ultrasound, thus making the adjunctive step of MRA a
helpful one to discover some anatomic limitations that might make
carotid stenting difficult.
The authors presented a very respectable clinical series of 60
patients, with only one death and no strokes. The stroke rate clearly
represents fine work that rivals some of the best reports in the
literature and clearly exceeds some of the early reports of 9% stroke
rates in the mid-90s. Currently, stroke rates are reported in the 3%
to 6% range, with the most scientifically valid randomized clinical
trials of EVA 3S and SPACE reporting rates of 6%, which brings to
light the first question. You had no strokes in your series, and one
presumed cardiac death. Can you provide us with a glimpse of your
carotid experience? This report represents two thirds of your total
cases. Did you do 30 cases first and then embark on MRA to assist
in case planning? Specifically, how many cases did you accomplish
prior to the series to reach the rate of no strokes?
When we look at our series from UAB in the 90s, we found
our learning curve to be almost 300 patients before the stroke rate
plunged from 9% to 3%. Some experts have suggested a learning
curve of 50 cases before one can be considered an experienced
carotid interventionalist. My personal experience, which suggests
learning from other nonsurgical “experts,” would place the learn-
ing curve well below the 50 cases that some have suggested or even
30 cases in some of the randomized protocols. I would appreciate
your comment on that principle of learning curve.
Second, I suspect many carotid interventionalists would sug-
gest the MRA is not required once you gained that initial experi-
ence. That is, an arteriogram will define the anatomic limitations
that would direct you to what catheter guide to use to cannulate
the vessel of interest. Additionally, the duplex scan should define
the location of stenosis, whether it is proximal or distal to the
external origin, and the initial angiogram can define the distal and
the proximal morphology to determine the best protection device.
Said more plainly, can’t you simply figure this out when you get
there rather than spending a few thousand dollars on a MRA prior
to the procedure?
Finally, I suspect you are using thisMRA to aid in the planning
process during your learning curve. This tool can help you decide
whether to take this patient to the next step of an angiogram and
stenting; therefore, theMRAwould be a nice planning tool to limit
the length or slope of your learning curve, particularly if you can
limit all strokes by avoiding complex anatomy as you have done in
this series. So, was the additional anatomic information reallyWhat about those patients that have a pacemaker or defibril-
lator? You know, those are being implanted almost as fast as carotid
stents these days. It seems that CT angio could provide the same
information and, actually, why not simply a time-of-flightMR scan
or a noncontrast CT scan? We can get lots of information this way.
Once again, let me congratulate you on your presentation and
the elegant statistical analysis that your manuscript accomplishes
on using this mechanism, but let me remind the rest of here today
that we as vascular surgeons remain the single discpline that can
offer both modalities of carotid surgery and stenting for a more
balanced approach of treating carotid disease. Thank you for
providing me a copy of the manuscript in a timely fashion well
before the meeting and for the privilege of the floor to discuss this
paper.
Dr Carlos Timaran: I was fortunate to perform a fair amount
of carotid stenting cases during my fellowship training prior to
joining UT Southwestern. I did my fellowship with Drs Ohki and
Veith at Montefiore Medical Center, and I was probably able to
perform about 50 carotid stenting cases as the primary operator
and another 50 or 60 cases as the assistant. Obviously, training and
experience give you some advantage, but I still believe you have to
plan these cases thoroughly because you never know what you are
going to encounter anatomically.
Of note, it is curious that I only began to use CE-MRA for
planning carotid stenting when I joinedUT Southwestern, primar-
ily because the patients that were referred for carotid interventions
already hadMRAs, which were usually of excellent quality. Clearly,
I was really pleased to see such MRA images. I was also able to do
all kinds of 3D reconstructions and manipulations of the images
using software, which prompted me to obtain CE-MRAs in every-
body considered for carotid stenting. Indeed, we currently do it for
almost everybody, except for those patients that have contraindi-
cations for MRI, including patients with pacemakers or defibrilla-
tors. Again, we try to get it in every patient, and despite our
increasing experience, we have not changed our practice.
Initially, we did it primarily because we had limited resources,
so CE-MRA allowed us to know if we needed to get extra materials
that we did not have in our shelves. Currently, we have almost
everything that is available for carotid stenting, but we still obtain
CE-MRA for different reasons. I think it is very important, partic-
ularly in teaching institutions, to go over these cases in detail prior
to the actual procedures with trainees because this may result in a
more expeditious procedure with decreased catheter and wire
manipulation of the aortic arch and the carotid arteries.
I think that if you get CE-MRA prior to carotid stenting with
excellent imaging, the learning curve may actually be shortened
because you do not have to do as many cases to learn different
alternatives. In fact, MRAs can certainly allow you to plan these
procedures more effectively. Obviously, carotid duplex gives you a
lot of information, but I prefer to see the images and do the 3D
reconstructions myself. Moreover, if you have a symptomatic pa-
tient, you are going to have to image the brain anyway, and
CE-MRA does not addmuch time or effort to a regular brainMRI.
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recent studies have shown that plaque composition can actually
be assessed with carotid coils. Thus, I think MRI is going to be
probably the tool of choice to evaluate carotid stenosis because
brain MRI, aortic arch and carotid MRA, and plaque composi-
tion will all be obtained in one setting. For patients with
rience and the types of protection devices available. In addition,contradictions for MRI, CTA is the best option as well as for
patients with heavy calcification and octogenarians. For the
latter, CTA is particularly important because it is imperative not
only to image the arch but also to assess the vessel wall as plaque
at this level can be the source of emboli during carotid stenting
in elderly patients.INVITED COMMENTARYChristopher J. Kwolek, MD, Boston, Mass
Dr Timaran and his colleagues have provided us with a timely
article discussing the potential use of magnetic resonance angiog-
raphy (MRA) in the preprocedural evaluation of patients undergo-
ing carotid angioplasty and stenting (CAS). This has become more
relevant given the recent publication of several trials which call into
question the efficacy of CAS compared with CEA for stroke
prevention. Discussion of these papers has once again brought out
the importance of careful patient selection, appropriate physician
training and experience, along with careful preprocedural planning
to minimize the risk of complications associated with CAS.
MRA may prove useful in identifying individual anatomic
factors such as the presence of ulcerated plaque, arch type, and
severe tortuosity. However, suitability for stenting is based not
only on anatomic factors, but also the individual physician’s expe-some institutions may prefer computed tomography angiograms
(CTA) as a more readily available or easier to interpret form of
noninvasive arterial imaging.
The current study is also limited in its generalized applica-
bility given the fact that only one woman and no patients over
the age of 80 were included in the evaluation. It is now well
recognized that octogenarians comprise a high risk subset of
patients undergoing CAS.
Future studies will hopefully elucidate which patients will
benefit most from preprocedural MR angiogram. In addition, it
will be important to justify the additional cost associated with this
procedure, since many centers report excellent results without
using MRA. Perhaps, it will be most useful for operators early in
their learning curve or in certain high risk groups of patients who
may have more complex anatomy such as those over the age of 80.
